| 000 | 01461 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516102752.0 | ||
| 264 | 0 | _c20120912 | |
| 008 | 201209s 0 0 rus d | ||
| 022 | _a0023-1207 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatusevich, E A | |
| 245 | 0 | 0 |
_a[The immune activity of cytoflavine in the treatment of the diffuse septic peritonitis]. _h[electronic resource] |
| 260 |
_bKhirurgiia _c2012 |
||
| 300 |
_a72-5 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFlavin Mononucleotide _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 |
_aInosine Diphosphate _xadministration & dosage |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMonitoring, Immunologic |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 |
_aPerioperative Care _xmethods |
| 650 | 0 | 4 |
_aPeritonitis _xcomplications |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSuccinates _xadministration & dosage |
| 650 | 0 | 4 |
_aSuppuration _xetiology |
| 650 | 0 | 4 |
_aSurgical Procedures, Operative _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tKhirurgiia _gno. 5 _gp. 72-5 |
|
| 999 |
_c21957001 _d21957001 |
||